Literature DB >> 32187526

Serine Catabolism Feeds NADH when Respiration Is Impaired.

Lifeng Yang1, Juan Carlos Garcia Canaveras1, Zihong Chen1, Lin Wang1, Lingfan Liang2, Cholsoon Jang1, Johannes A Mayr3, Zhaoyue Zhang1, Jonathan M Ghergurovich4, Le Zhan5, Shilpy Joshi5, Zhixian Hu5, Melanie R McReynolds1, Xiaoyang Su6, Eileen White7, Raphael J Morscher8, Joshua D Rabinowitz9.   

Abstract

NADH provides electrons for aerobic ATP production. In cells deprived of oxygen or with impaired electron transport chain activity, NADH accumulation can be toxic. To minimize such toxicity, elevated NADH inhibits the classical NADH-producing pathways: glucose, glutamine, and fat oxidation. Here, through deuterium-tracing studies in cultured cells and mice, we show that folate-dependent serine catabolism also produces substantial NADH. Strikingly, when respiration is impaired, serine catabolism through methylene tetrahydrofolate dehydrogenase (MTHFD2) becomes a major NADH source. In cells whose respiration is slowed by hypoxia, metformin, or genetic lesions, mitochondrial serine catabolism inhibition partially normalizes NADH levels and facilitates cell growth. In mice with engineered mitochondrial complex I deficiency (NDUSF4-/-), serine's contribution to NADH is elevated, and progression of spasticity is modestly slowed by pharmacological blockade of serine degradation. Thus, when respiration is impaired, serine catabolism contributes to toxic NADH accumulation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MTHFD2; NAD; NADH; SHMT2; complex I inhibitor; hypoxia; methylene tetrahydrofolate dehydrogenase; mitochondrial disease; redox; respiration inhibition; serine catabolism; serine hydroxymethyltransferase

Year:  2020        PMID: 32187526      PMCID: PMC7397714          DOI: 10.1016/j.cmet.2020.02.017

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  71 in total

Review 1.  The key role of anaplerosis and cataplerosis for citric acid cycle function.

Authors:  Oliver E Owen; Satish C Kalhan; Richard W Hanson
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

Review 2.  Molecular Regulation of Fatty Acid Oxidation in Skeletal Muscle during Aerobic Exercise.

Authors:  Anne-Marie Lundsgaard; Andreas Mæchel Fritzen; Bente Kiens
Journal:  Trends Endocrinol Metab       Date:  2017-12-05       Impact factor: 12.015

3.  Pyruvate therapy for mitochondrial DNA depletion syndrome.

Authors:  Keiko Saito; Nobusuke Kimura; Nozomi Oda; Hideki Shimomura; Tomohiro Kumada; Tomoko Miyajima; Kei Murayama; Masashi Tanaka; Tatsuya Fujii
Journal:  Biochim Biophys Acta       Date:  2011-08-11

4.  Cellular redox state constrains serine synthesis and nucleotide production to impact cell proliferation.

Authors:  Frances F Diehl; Caroline A Lewis; Brian P Fiske; Matthew G Vander Heiden
Journal:  Nat Metab       Date:  2019-09-16

Review 5.  Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases.

Authors:  Kei Murayama; Masaru Shimura; Zhimei Liu; Yasushi Okazaki; Akira Ohtake
Journal:  J Hum Genet       Date:  2018-11-21       Impact factor: 3.172

6.  Mitochondrial reactive oxygen species trigger hypoxia-induced transcription.

Authors:  N S Chandel; E Maltepe; E Goldwasser; C E Mathieu; M C Simon; P T Schumacker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

7.  Efficacy of pyruvate therapy in patients with mitochondrial disease: a semi-quantitative clinical evaluation study.

Authors:  Tatsuya Fujii; Fumihito Nozaki; Keiko Saito; Anri Hayashi; Yutaka Nishigaki; Kei Murayama; Masashi Tanaka; Yasutoshi Koga; Ikuko Hiejima; Tomohiro Kumada
Journal:  Mol Genet Metab       Date:  2014-05-02       Impact factor: 4.797

8.  ElemCor: accurate data analysis and enrichment calculation for high-resolution LC-MS stable isotope labeling experiments.

Authors:  Di Du; Lin Tan; Yumeng Wang; Bo Peng; John N Weinstein; Fredric E Wondisford; Xiaoyang Su; Philip L Lorenzi
Journal:  BMC Bioinformatics       Date:  2019-02-19       Impact factor: 3.169

9.  Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis.

Authors:  Joanna Kalucka; Laura Bierhansl; Nadine Vasconcelos Conchinha; Rindert Missiaen; Ilaria Elia; Ulrike Brüning; Samantha Scheinok; Lucas Treps; Anna Rita Cantelmo; Charlotte Dubois; Pauline de Zeeuw; Jermaine Goveia; Annalisa Zecchin; Federico Taverna; Francisco Morales-Rodriguez; Aleksandra Brajic; Lena-Christin Conradi; Sandra Schoors; Ulrike Harjes; Kim Vriens; Gregor-Alexander Pilz; Rongyuan Chen; Richard Cubbon; Bernard Thienpont; Bert Cruys; Brian W Wong; Bart Ghesquière; Mieke Dewerchin; Katrien De Bock; Xavier Sagaert; Sebastian Jessberger; Elizabeth A V Jones; Bernard Gallez; Diether Lambrechts; Massimiliano Mazzone; Guy Eelen; Xuri Li; Sarah-Maria Fendt; Peter Carmeliet
Journal:  Cell Metab       Date:  2018-08-23       Impact factor: 27.287

10.  Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo.

Authors:  Anila K Madiraju; Yang Qiu; Rachel J Perry; Yasmeen Rahimi; Xian-Man Zhang; Dongyan Zhang; João-Paulo G Camporez; Gary W Cline; Gina M Butrico; Bruce E Kemp; Gregori Casals; Gregory R Steinberg; Daniel F Vatner; Kitt F Petersen; Gerald I Shulman
Journal:  Nat Med       Date:  2018-07-23       Impact factor: 53.440

View more
  43 in total

Review 1.  Mitochondrial Metabolism as a Target for Cancer Therapy.

Authors:  Karthik Vasan; Marie Werner; Navdeep S Chandel
Journal:  Cell Metab       Date:  2020-07-14       Impact factor: 27.287

Review 2.  Cancer Cells Don't Live Alone: Metabolic Communication within Tumor Microenvironments.

Authors:  Fuming Li; M Celeste Simon
Journal:  Dev Cell       Date:  2020-07-07       Impact factor: 12.270

3.  NAD+ Regeneration Rescues Lifespan, but Not Ataxia, in a Mouse Model of Brain Mitochondrial Complex I Dysfunction.

Authors:  Gregory S McElroy; Colleen R Reczek; Paul A Reyfman; Divakar S Mithal; Craig M Horbinski; Navdeep S Chandel
Journal:  Cell Metab       Date:  2020-06-22       Impact factor: 27.287

Review 4.  Reprogramming of serine, glycine and one-carbon metabolism in cancer.

Authors:  Albert M Li; Jiangbin Ye
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-05-19       Impact factor: 5.187

Review 5.  Targeting adaptive cellular responses to mitochondrial bioenergetic deficiencies in human disease.

Authors:  Christopher F Bennett; Conor T Ronayne; Pere Puigserver
Journal:  FEBS J       Date:  2021-09-12       Impact factor: 5.542

6.  Ketogenic diet and chemotherapy combine to disrupt pancreatic cancer metabolism and growth.

Authors:  Lifeng Yang; Tara TeSlaa; Serina Ng; Michel Nofal; Lin Wang; Taijin Lan; Xianfeng Zeng; Alexis Cowan; Matthew McBride; Wenyun Lu; Shawn Davidson; Gaoyang Liang; Tae Gyu Oh; Michael Downes; Ronald Evans; Daniel Von Hoff; Jessie Yanxiang Guo; Haiyong Han; Joshua D Rabinowitz
Journal:  Med (N Y)       Date:  2022-02-11

Review 7.  Potential of electron transfer and its application in dictating routes of biochemical processes associated with metabolic reprogramming.

Authors:  Ronghui Yang; Guoguang Ying; Binghui Li
Journal:  Front Med       Date:  2021-07-24       Impact factor: 4.592

Review 8.  A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.

Authors:  Christine R Cuthbertson; Zahra Arabzada; Armand Bankhead; Armita Kyani; Nouri Neamati
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-01

9.  Multi-OMICS study of a CHCHD10 variant causing ALS demonstrates metabolic rewiring and activation of endoplasmic reticulum and mitochondrial unfolded protein responses.

Authors:  Isabella R Straub; Woranontee Weraarpachai; Eric A Shoubridge
Journal:  Hum Mol Genet       Date:  2021-05-17       Impact factor: 6.150

Review 10.  Designing Relevant Preclinical Rodent Models for Studying Links Between Nutrition, Obesity, Metabolism, and Cancer.

Authors:  Elaine M Glenny; Michael F Coleman; Erin D Giles; Elizabeth A Wellberg; Stephen D Hursting
Journal:  Annu Rev Nutr       Date:  2021-08-06       Impact factor: 11.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.